112 related articles for article (PubMed ID: 2895446)
1. Amplification of human int-2 in breast cancers and squamous carcinomas.
Zhou DJ; Casey G; Cline MJ
Oncogene; 1988 Mar; 2(3):279-82. PubMed ID: 2895446
[TBL] [Abstract][Full Text] [Related]
2. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
4. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Berenson JR; Yang J; Mickel RA
Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705
[TBL] [Abstract][Full Text] [Related]
5. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
Volling P; Jungehülsing M; Tesch H; Stennert E
Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
[TBL] [Abstract][Full Text] [Related]
6. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
Ali IU; Merlo G; Callahan R; Lidereau R
Oncogene; 1989 Jan; 4(1):89-92. PubMed ID: 2915903
[TBL] [Abstract][Full Text] [Related]
7. Frequent novel DNA copy number increase in squamous cell head and neck tumors.
Brzoska PM; Levin NA; Fu KK; Kaplan MJ; Singer MI; Gray JW; Christman MF
Cancer Res; 1995 Jul; 55(14):3055-9. PubMed ID: 7606727
[TBL] [Abstract][Full Text] [Related]
8. Absence of ST7 gene alterations in human cancer.
Dong SM; Sidransky D
Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the int-2 gene in primary human breast tumors.
Lidereau R; Callahan R; Dickson C; Peters G; Escot C; Ali IU
Oncogene Res; 1988 Feb; 2(3):285-91. PubMed ID: 2835739
[TBL] [Abstract][Full Text] [Related]
10. Variability of genetic alterations in different sites of head and neck cancer.
Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes in head and neck cancer.
Irish JC; Bernstein A
Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
[TBL] [Abstract][Full Text] [Related]
12. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB
J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas.
Fietkau R; Iro H; Tulusan AH; Dressel V; Altendorf-Hofmann A; Sauer R
Strahlenther Onkol; 1994 Jan; 170(1):13-24. PubMed ID: 8303573
[TBL] [Abstract][Full Text] [Related]
14. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
[TBL] [Abstract][Full Text] [Related]
15. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
17. Oncogenes: preliminary studies in head and neck cancer.
Friedman WH; Rosenblum B; Loewenstein P; Thornton H; Katsantonis G; Green M
Laryngoscope; 1983 Nov; 93(11 Pt 1):1441-4. PubMed ID: 6633116
[TBL] [Abstract][Full Text] [Related]
18. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
[TBL] [Abstract][Full Text] [Related]
19. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD
Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396
[TBL] [Abstract][Full Text] [Related]
20. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
